Short interest data from late October 2026 highlights deeply divided investor sentiment across healthcare stocks. Heavy bearish bets remain concentrated in high-volatility biotechnology and pharmaceutical names, led by Biodexa Pharmaceuticals (BDRX) and
CryptoAlerta — análise de criptomoedas e mercado em tempo real